Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03495011 · ClinicalTrials.gov registry record
MRI Characterization of Mammographically Detected DCIS
A clinical trial of Breast Cancer Stage 0, sponsored by University of Washington.
- Active
- Registry status
- 122
- Enrollment target
- 1
- Study location
NCT03495011 is a study of Breast Cancer Stage 0 that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 122 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03495011, a study of Breast Cancer Stage 0, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- 122 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single institution, prospective observational clinical trial for women with mammographically identified calcifications that may represent ductal carcinoma in situ (DCIS). The purpose of this study is to determine whether quantitative, multiparametric breast MRI performed prior to surgical resection can biologically characterize this common pre-invasive malignancy, ductal carcinoma in situ (DCIS), which typically presents in asymptomatic women as suspicious calcifications on mammography.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- DIAGNOSTIC_TEST Breast MRI
Study Locations (1)
Washington
- Fred Hutch/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2018-04-20 |
| Est. Completion | 2032-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03495011
The ClinicalTrials.gov registry entry for NCT03495011 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer Stage 0 appearing as the primary indexed condition, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03495011 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT03495011 about?
NCT03495011 is a clinical study titled "MRI Characterization of Mammographically Detected DCIS". This is a single institution, prospective observational clinical trial for women with mammographically identified calcifications that may represent ductal carcinoma in situ (DCIS). The purpose of this study is to determine whether quantitative, multiparametric breast MRI performed prior to surgical...
What is the current status of trial NCT03495011?
This trial is currently active not recruiting. The enrollment target is 122 participants. The study started on 2018-04-20. Estimated completion is 2032-04.
What conditions does trial NCT03495011 study?
This clinical trial studies the following conditions: Breast Cancer Stage 0.
What interventions are being tested in trial NCT03495011?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Breast MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03495011?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03495011 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Stage 0
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.